Связь гемокоагуляции и плацентации у человека

Закрыть метаданные

Рекомендуем статьи по данной теме:

К вопросу о структурной реорганизации в плацентах женщин, перенесших COVID-19 в I и II триместрах беременности. Российский вестник акушера-гинеколога. 2023;(2):5-10

Изменения гемокоагуляции при физиологически протекающей беременности. Российский вестник акушера-гинеколога. 2023;(2):26-33

Акушерские осложнения гестационного сахарного диабета, возникшего у беременных после применения вспомогательных репродуктивных технологий. Российский вестник акушера-гинеколога. 2023;(3):7-11

Акушерские, неонатальные осложнения и исход родов в зависимости от фенотипа эндометриоза и объема хирургического лечения. Российский вестник акушера-гинеколога. 2023;(3):29-40

Потенциальная роль нейтрофильных внеклеточных ловушек в патогенезе преэклампсии. Проблемы репродукции. 2023;(1):63-72

Морфологическая характеристика плаценты при монохориальной диамниотической двойне, осложненной синдромом селективной задержки роста плода. Проблемы репродукции. 2023;(1):79-85

Клинико-морфологическая характеристика спектра атипичной плацентации в матке. Архив патологии. 2023;(2):13-20

Влияние гестационного сахарного диабета на риск развития акушерских и перинатальных осложнений у беременных после вспомогательных репродуктивных технологий. Проблемы репродукции. 2023;(2):31-41

Роль тучных клеток при физиологической и осложненной беременности. Архив патологии. 2023;(3):75-81

В обзоре представлены данные об участии факторов гемокоагуляции в процессе развития плаценты у человека. Обсуждается связь нарушений параметров гемокоагуляции с патологией плацентации и формированием осложнений беременности. Объясняется вероятность частого формирования осложнений беременности при врожденных дефектах гемокоагуляции. Обосновывается целесообразность лечения препаратами, влияющими на гемокоагуляцию, для улучшения исходов беременности.

Ключевые слова:

факторы гемокоагуляции

факторы роста

плацента

вспомогательные репродуктивные технологии

осложнения беременности

Авторы:

Мельников А.П.

ГБУЗ МО «Московский областной научно-исследовательский институт акушерства и гинекологии» Минздрава Московской области

ORCID: 0000-0002-7426-9040

Острина С.Я.

ГБУЗ МО «Московский областной перинатальный центр»

ORCID: 0000-0002-3865-8276

Дата поступления:

02.09.2022

Дата принятия в печать:

12.09.2022

Список литературы:

Goncharov NV, Popova PI, Avdonin PP, Kudryavtsev IV, Serebryakova MK, Korf EA, Avdonin PV. Markers of endothelial cells in normal and pathological conditions. Biochem (Mosc) Suppl Ser A Membr Cell Biol. 2020;14:3:167-183. https://doi.org/10.1134/S1990747819030140
Gadde R, Cd D, Sheela SR. Placental protein 13: An important biological protein in preeclampsia. J Circ Biomark. 2018;7:1849454418786159. https://doi.org/10.1177/1849454418786159
Maybin JA, Critchley HO. Menstrual physiology: implications for endometrial pathology and beyond. Hum Reprod Update. 2015;21:6:748-761. https://doi.org/10.1093/humupd/dmv038
Schatz F, Guzeloglu-Kayisli O, Arlier S, Kayisli UA, Lockwood CJ. The role of decidual cells in uterine hemostasis, menstruation, inflammation, adverse pregnancy outcomes and abnormal uterine bleeding. Hum Reprod Update. 2016;22:4:497-515. https://doi.org/10.1093/humupd/dmw004
Maybin JA, Hirani N, Brown P, Jabbour HN, Critchley HO. The regulation of vascular endothelial growth factor by hypoxia and prostaglandin F2α during human endometrial repair. J Clin Endocrinol Metab. 2011;96:8:2475-2483. https://doi.org/10.1210/jc.2010-2971
Hill AM, Stewart PW, Fung MK, Kris-Etherton PM, Ginsberg HN, Tracy RP, Pearson TA, Lefevre M, Reed RG, Elmer PJ, Holleran S, Ershow AG. Dietary effects on lipoproteins and thrombogenic activity investigators. Monthly haemostatic factor variability in women and men. Eur J Clin Invest. 2014;44:3:309-318. https://doi.org/10.1111/eci.12235
Alzahrani F, Hassan F. Modulation of platelet functions assessment during menstruation and ovulatory phases. J Med Life. 2019;12:3:296-300. https://doi.org/10.25122/jml-2019-0005
Bódis J, Papp S, Vermes I, Sulyok E, Tamás P, Farkas B, Zámbó K, Hatzipetros I, Kovács GL. «Platelet-associated regulatory system (PARS)» with particular reference to female reproduction. J Ovarian Res. 2014;7:55. https://doi.org/10.1186/1757-2215-7-55
Smith S, Francis R, Guilbert L, Baker PN. Growth factor rescue of cytokine mediated trophoblast apoptosis. Placenta. 2002;23:4:322-330. https://doi.org/10.1053/plac.2001.0783
Moser G, Guettler J, Forstner D, Gauster M. Maternal platelets—friend or foe of the human placenta? Int J Mol Sci. 2019;20:22:5639. https://doi.org/10.3390/ijms20225639
Kisucka J, Butterfield CE, Duda DG, Eichenberger SC, Saffaripour S, Ware J, Ruggeri ZM, Jain RK, Folkman J, Wagner DD. Platelets and platelet adhesion support angiogenesis while preventing excessive hemorrhage. Proc Natl Acad Sci U S A. 2006;103:4:855-860. https://doi.org/10.1073/pnas.0510412103
Schulman S, El-Darzi E, Florido MH, Friesen M, Merrill-Skoloff G, Brake MA, Schuster CR, Lin L, Westrick RJ, Cowan CA, Flaumenhaft R; NIHR BioResource, Ouwehand WH, Peerlinck K, Freson K, Turro E, Furie B. A coagulation defect arising from heterozygous premature termination of tissue factor. J Clin Invest. 2020;130:10:5302-5312. https://doi.org/10.1172/JCI133780
Mastrolia SA, Mazor M, Loverro G, Klaitman V, Erez O. Placental vascular pathology and increased thrombin generation as mechanisms of disease in obstetrical syndromes. Peer J. 2014;2:e653. https://doi.org/10.7717/peerj.653
Lockwood CJ, Paidas M, Murk WK, Kayisli UA, Gopinath A, Huang SJ, Krikun G, Schatz F. Involvement of human decidual cell-expressed tissue factor in uterine hemostasis and abruption. Thromb Res. 2009;124:5:516-520. https://doi.org/10.1016/j.thromres.2009.07.017
Li C, Li J, Li Y, Lang S, Yougbare I, Zhu G, Chen P, Ni H. Crosstalk between platelets and the immune system: old systems with new discoveries. Adv Hematol. 2012;2012:384685. https://doi.org/10.1155/2012/384685
Sato Y, Sugi T, Sakai R. Antigenic binding sites of anti-protein S autoantibodies in patients with recurrent pregnancy loss. Res Pract Thromb Haemost. 2018;2:2:357-365. https://doi.org/10.1002/rth2.12081
Nurden AT. Platelets and tissue remodeling: extending the role of the blood clotting system. Endocrinology. 2007;148:7:3053-3055. https://doi.org/10.1210/en.2007-0506
Mayoral Andrade G, Vásquez Martínez G, Pérez-Campos Mayoral L, Hernández-Huerta MT, Zenteno E, Pérez-Campos Mayoral E, Martínez Cruz M, Martínez Cruz R, Matias-Cervantes CA, Meraz Cruz N, Romero Díaz C, Cruz-Parada E, Pérez-Campos E. Molecules and prostaglandins related to embryo tolerance. Front Immunol. 2020;11:555414. https://doi.org/10.3389/fimmu.2020.555414
Sood R, Kalloway S, Mast AE, Hillard CJ, Weiler H. Fetomaternal cross talk in the placental vascular bed: control of coagulation by trophoblast cells. Blood. 2006;107:8:3173-3180. https://doi.org/10.1182/blood-2005-10-4111
Kirn-Safran CB, D’Souza SS, Carson DD. Heparan sulfate proteoglycans and their binding proteins in embryo implantation and placentation. Semin Cell Dev Biol. 2008;19:2:187-193. https://doi.org/10.1016/j.semcdb.2007.07.013
Grimaldi G, Christian M, Quenby S, Brosens JJ. Expression of epigenetic effectors in decidualizing human endometrial stromal cells. Mol Hum Reprod. 2012;18:9:451-458. https://doi.org/10.1093/molehr/gas020
El-Azzamy H, Dambaeva SV, Katukurundage D, Salazar Garcia MD, Skariah A, Hussein Y, Germain A, Fernandez E, Gilman-Sachs A, Beaman KD, Kwak-Kim J. Dysregulated uterine natural killer cells and vascular remodeling in women with recurrent pregnancy losses. Am J Reprod Immunol. 2018;80:4:e13024. https://doi.org/10.1111/aji.13024
Whitten AE, Romero R, Korzeniewski SJ, Tarca AL, Schwartz AG, Yeo L, Dong Z, Hassan SS, Chaiworapongsa T. Evidence of an imbalance of angiogenic/antiangiogenic factors in massive perivillous fibrin deposition (maternal floor infarction): a placental lesion associated with recurrent miscarriage and fetal death. Am J Obstet Gynecol. 2013;208:4:310.e1-310.e11. https://doi.org/10.1016/j.ajog.2013.01.017
Sood R, Sholl L, Isermann B, Zogg M, Coughlin SR, Weiler H. Maternal Par4 and platelets contribute to defective placenta formation in mouse embryos lacking thrombomodulin. Blood. 2008;112:3:585-591. https://doi.org/10.1182/blood-2007-09-111302
Seferovic MD, Gupta MB. Increased umbilical cord PAI-1 levels in placental insufficiency are associated with fetal hypoxia and angiogenesis. Dis Markers. 2016;2016:7124186. https://doi.org/10.1155/2016/7124186
Schneider BP, Miller KD. Angiogenesis of breast cancer. J Clin Oncol. 2005;23:8:1782-1790. https://doi.org/10.1200/JCO.2005.12.017
Kohli S, Singh KK, Gupta A, Markmeyer P, Lochmann F, Gupta D, Rana R, Elwakiel A, Huebner H, Ruebner M, Isermann B. Placental thromboinflammation impairs embryonic survival by reducing placental thrombomodulin expression. Blood. 2021;137:7:977-982. https://doi.org/10.1182/blood.2020005225
Marchi R, López Ramirez Y, Nagaswami C, Masova L, Pulido A, López Mora J, Muller A, Arocha-Piñango CL, Weisel JW. Haemostatic changes related to fibrin formation and fibrinolysis during the first trimester in normal pregnancy and in recurrent miscarriage. Thromb Haemost. 2007;97:4:552-527.
Sato Y, Sugi T, Sakai R. Anti-Factor XII autoantibodies in patients with recurrent pregnancy loss recognize the second epidermal growth factor-like domain. TH Open. 2019;3:3:e263-e272. https://doi.org/10.1055/s-0039-1695709
Matsubayashi H. Autoantibodies and coagulation in reproductive medicine. Reprod Med Biol. 2009;8:4:131-140. https://doi.org/10.1007/s12522-009-0026-9
Khosravi F, Zarei S, Ahmadvand N, Akbarzadeh-Pasha Z, Savadi E, Zarnani AH, Sadeghi MR, Jeddi-Tehrani M. Association between plasminogen activator inhibitor 1 gene mutation and different subgroups of recurrent miscarriage and implantation failure. J Assist Reprod Genet. 2014;31:1:121-124. https://doi.org/10.1007/s10815-013-0125-8
Shi DY, Wang SJ. Advances of coagulation factor XIII. Chin Med J (Engl). 2017;130:2:219-223.
Burstyn-Cohen T, Heeb MJ, Lemke G. Lack of protein S in mice causes embryonic lethal coagulopathy and vascular dysgenesis. J Clin Invest. 2009;119:10:2942-2953. https://doi.org/10.1172/JCI39325
Marozio L, Curti A, Botta G, Canuto EM, Salton L, Tavella AM, Benedetto C. Anti-prothrombin antibodies are associated with adverse pregnancy outcome. Am J Reprod Immunol. 2011;66:5:404-409. https://doi.org/10.1111/j.1600-0897.2011.01031.x
Girardi G. Role of tissue factor in feto-maternal development: a xiphos. J Thromb Haemost. 2011;9:2:250-256. https://doi.org/10.1111/j.1538-7836.2010.04135.x
Elovitz MA, Baron J, Phillippe M. The role of thrombin in preterm parturition. Am J Obstet Gynecol. 2001;185:5:1059-1063. https://doi.org/10.1067/mob.2001.117638
Rosen T, Schatz F, Kuczynski E, Lam H, Koo AB, Lockwood CJ. Thrombin-enhanced matrix metalloproteinase-1 expression: a mechanism linking placental abruption with premature rupture of the membranes. J Matern Fetal Neonatal Med. 2002;11:1:11-17. https://doi.org/10.1080/jmf.11.1.11.17
Gerotziafas GT, Van Dreden P, Mathieu d’Argent E, Lefkou E, Grusse M, Comtet M, Sangare R, Ketatni H, Larsen AK, Elalamy I. Impact of blood hypercoagulability on in vitro fertilization outcomes: a prospective longitudinal observational study. Thromb J. 2017;15:9. https://doi.org/10.1186/s12959-017-0131-7
Romagnuolo I, Sticchi E, Fedi S, Cellai AP, Lami D, Alessandrello Liotta A, Rogolino A, Cioni G, Noci I, Abbate R, Fatini C. Is tissue factor pathway inhibitor a marker of procoagulable status in healthy infertile women undergoing ovarian stimulation for assisted reproduction? Blood Coagul Fibrinolysis. 2014;25:3:254-258. https://doi.org/10.1097/MBC.0000000000000044
Altmäe S, Salumets A, Bjuresten K, Kallak TK, Wånggren K, Landgren BM, Hovatta O, Stavreus-Evers A. Tissue factor and tissue factor pathway inhibitors TFPI and TFPI2 in human secretory endometrium — possible link to female infertility. Reprod Sci. 2011;18:7:666-678. https://doi.org/10.1177/1933719111400633
Di Nisio M, Porreca E, Di Donato V, Tiboni GM. Plasma concentrations of D-dimer and outcome of in vitro fertilization. J Ovarian Res. 2014;7:58. https://doi.org/10.1186/1757-2215-7-58
Zhao L, Sun L, Zheng X, Liu J, Zheng R, Yang R, Wang Y. Alterations in complement and coagulation pathways of human placentae subjected to in vitro fertilization and embryo transfer in the first trimester. Medicine (Baltimore). 2019;98:44:e17031. https://doi.org/10.1097/MD.0000000000017031
Yagel S. Angiogenesis in gestational vascular complications. Thromb Res. 2011;127(suppl 3):64-66. https://doi.org/10.1016/S0049-3848(11)70018-4
Hamdi K, Danaii S, Farzadi L, Abdollahi S, Chalabizadeh A, Abdollahi Sabet S. The role of heparin in embryo implantation in women with recurrent implantation failure in the cycles of assisted reproductive techniques (without history of thrombophilia). J Family Reprod Health. 2015;9:2:59-64.
Di Micco P, Russo V, Mastroiacovo D, Bosevski M, Lodigiani C. In vitro fertilization procedures with embryo transfer and their association with thrombophilia, thrombosis and early antithrombotic treatments. J Blood Med. 2020;11:185-190. https://doi.org/10.2147/JBM.S248988

Закрыть метаданные